Polyomavirus BK infection in pediatric kidney-allograft recipients

A single-center analysis of incidence, risk factors, and novel therapeutic approaches

F. Ginevri, R. De Santis, P. Comoli, N. Pastorino, C. Rossi, G. Botti, I. Fontana, A. Nocera, M. Cardillo, M. R. Ciardi, F. Locatelli, R. Maccario, F. Perfumo, A. Azzi

Research output: Contribution to journalArticle

147 Citations (Scopus)

Abstract

Background. Although a growing body of literature regarding polyoma BK virus (BKV) infection and associated interstitial nephritis in kidney-allograft recipients is becoming available, the impact of BKV infection in the pediatric population has not been fully evaluated. Methods. In a retrospective analysis, we performed polymerase chain reaction (PCR) assays for BKV DNA in serum and urine samples from 100 pediatric kidney-allograft recipients referred to our institution in the last 5 years. Results. BKV viruria was observed in 26 of 100 patients, whereas BKV viremia was demonstrated in 5 patients. Serum creatinine was significantly higher in recipients with positive BK viremia compared with BKV DNA-negative patients (mean 2.66 vs. 1.14 mg/100 mL). Renal biopsy performed in 3 of 5 patients showed graft damage consistent with interstitial nephropathy. In the univariate analysis, negative antibody status of the recipient and the presence of mycophenolate mofetil in baseline immunosuppression were the two factors predictive of active BKV infection. Conclusions. Our study shows that BKV-associated nephropathy is a relevant complication in the pediatric kidney transplantation setting also. Identification of patients at risk of developing virus-associated nephropathy, through prospective quantification of viral load, could improve clinical outcome by allowing the use of timely preemptive therapy guided by BKV DNA levels.

Original languageEnglish
Pages (from-to)1266-1270
Number of pages5
JournalTransplantation
Volume75
Issue number8
DOIs
Publication statusPublished - Apr 27 2003

Fingerprint

Polyomavirus Infections
BK Virus
Allografts
Pediatrics
Kidney
Incidence
Virus Diseases
Therapeutics
Viremia
DNA
Mycophenolic Acid
Interstitial Nephritis
Polyomavirus
Viral Load
Serum
Kidney Transplantation
Immunosuppression
Creatinine
Urine

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Polyomavirus BK infection in pediatric kidney-allograft recipients : A single-center analysis of incidence, risk factors, and novel therapeutic approaches. / Ginevri, F.; De Santis, R.; Comoli, P.; Pastorino, N.; Rossi, C.; Botti, G.; Fontana, I.; Nocera, A.; Cardillo, M.; Ciardi, M. R.; Locatelli, F.; Maccario, R.; Perfumo, F.; Azzi, A.

In: Transplantation, Vol. 75, No. 8, 27.04.2003, p. 1266-1270.

Research output: Contribution to journalArticle

Ginevri, F, De Santis, R, Comoli, P, Pastorino, N, Rossi, C, Botti, G, Fontana, I, Nocera, A, Cardillo, M, Ciardi, MR, Locatelli, F, Maccario, R, Perfumo, F & Azzi, A 2003, 'Polyomavirus BK infection in pediatric kidney-allograft recipients: A single-center analysis of incidence, risk factors, and novel therapeutic approaches', Transplantation, vol. 75, no. 8, pp. 1266-1270. https://doi.org/10.1097/01.TP.0000061767.32870.72
Ginevri, F. ; De Santis, R. ; Comoli, P. ; Pastorino, N. ; Rossi, C. ; Botti, G. ; Fontana, I. ; Nocera, A. ; Cardillo, M. ; Ciardi, M. R. ; Locatelli, F. ; Maccario, R. ; Perfumo, F. ; Azzi, A. / Polyomavirus BK infection in pediatric kidney-allograft recipients : A single-center analysis of incidence, risk factors, and novel therapeutic approaches. In: Transplantation. 2003 ; Vol. 75, No. 8. pp. 1266-1270.
@article{5dc79ca275e14ceaa1d1b2ff1a06a504,
title = "Polyomavirus BK infection in pediatric kidney-allograft recipients: A single-center analysis of incidence, risk factors, and novel therapeutic approaches",
abstract = "Background. Although a growing body of literature regarding polyoma BK virus (BKV) infection and associated interstitial nephritis in kidney-allograft recipients is becoming available, the impact of BKV infection in the pediatric population has not been fully evaluated. Methods. In a retrospective analysis, we performed polymerase chain reaction (PCR) assays for BKV DNA in serum and urine samples from 100 pediatric kidney-allograft recipients referred to our institution in the last 5 years. Results. BKV viruria was observed in 26 of 100 patients, whereas BKV viremia was demonstrated in 5 patients. Serum creatinine was significantly higher in recipients with positive BK viremia compared with BKV DNA-negative patients (mean 2.66 vs. 1.14 mg/100 mL). Renal biopsy performed in 3 of 5 patients showed graft damage consistent with interstitial nephropathy. In the univariate analysis, negative antibody status of the recipient and the presence of mycophenolate mofetil in baseline immunosuppression were the two factors predictive of active BKV infection. Conclusions. Our study shows that BKV-associated nephropathy is a relevant complication in the pediatric kidney transplantation setting also. Identification of patients at risk of developing virus-associated nephropathy, through prospective quantification of viral load, could improve clinical outcome by allowing the use of timely preemptive therapy guided by BKV DNA levels.",
author = "F. Ginevri and {De Santis}, R. and P. Comoli and N. Pastorino and C. Rossi and G. Botti and I. Fontana and A. Nocera and M. Cardillo and Ciardi, {M. R.} and F. Locatelli and R. Maccario and F. Perfumo and A. Azzi",
year = "2003",
month = "4",
day = "27",
doi = "10.1097/01.TP.0000061767.32870.72",
language = "English",
volume = "75",
pages = "1266--1270",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Polyomavirus BK infection in pediatric kidney-allograft recipients

T2 - A single-center analysis of incidence, risk factors, and novel therapeutic approaches

AU - Ginevri, F.

AU - De Santis, R.

AU - Comoli, P.

AU - Pastorino, N.

AU - Rossi, C.

AU - Botti, G.

AU - Fontana, I.

AU - Nocera, A.

AU - Cardillo, M.

AU - Ciardi, M. R.

AU - Locatelli, F.

AU - Maccario, R.

AU - Perfumo, F.

AU - Azzi, A.

PY - 2003/4/27

Y1 - 2003/4/27

N2 - Background. Although a growing body of literature regarding polyoma BK virus (BKV) infection and associated interstitial nephritis in kidney-allograft recipients is becoming available, the impact of BKV infection in the pediatric population has not been fully evaluated. Methods. In a retrospective analysis, we performed polymerase chain reaction (PCR) assays for BKV DNA in serum and urine samples from 100 pediatric kidney-allograft recipients referred to our institution in the last 5 years. Results. BKV viruria was observed in 26 of 100 patients, whereas BKV viremia was demonstrated in 5 patients. Serum creatinine was significantly higher in recipients with positive BK viremia compared with BKV DNA-negative patients (mean 2.66 vs. 1.14 mg/100 mL). Renal biopsy performed in 3 of 5 patients showed graft damage consistent with interstitial nephropathy. In the univariate analysis, negative antibody status of the recipient and the presence of mycophenolate mofetil in baseline immunosuppression were the two factors predictive of active BKV infection. Conclusions. Our study shows that BKV-associated nephropathy is a relevant complication in the pediatric kidney transplantation setting also. Identification of patients at risk of developing virus-associated nephropathy, through prospective quantification of viral load, could improve clinical outcome by allowing the use of timely preemptive therapy guided by BKV DNA levels.

AB - Background. Although a growing body of literature regarding polyoma BK virus (BKV) infection and associated interstitial nephritis in kidney-allograft recipients is becoming available, the impact of BKV infection in the pediatric population has not been fully evaluated. Methods. In a retrospective analysis, we performed polymerase chain reaction (PCR) assays for BKV DNA in serum and urine samples from 100 pediatric kidney-allograft recipients referred to our institution in the last 5 years. Results. BKV viruria was observed in 26 of 100 patients, whereas BKV viremia was demonstrated in 5 patients. Serum creatinine was significantly higher in recipients with positive BK viremia compared with BKV DNA-negative patients (mean 2.66 vs. 1.14 mg/100 mL). Renal biopsy performed in 3 of 5 patients showed graft damage consistent with interstitial nephropathy. In the univariate analysis, negative antibody status of the recipient and the presence of mycophenolate mofetil in baseline immunosuppression were the two factors predictive of active BKV infection. Conclusions. Our study shows that BKV-associated nephropathy is a relevant complication in the pediatric kidney transplantation setting also. Identification of patients at risk of developing virus-associated nephropathy, through prospective quantification of viral load, could improve clinical outcome by allowing the use of timely preemptive therapy guided by BKV DNA levels.

UR - http://www.scopus.com/inward/record.url?scp=0242585412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242585412&partnerID=8YFLogxK

U2 - 10.1097/01.TP.0000061767.32870.72

DO - 10.1097/01.TP.0000061767.32870.72

M3 - Article

VL - 75

SP - 1266

EP - 1270

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 8

ER -